Sunshine Biopharma Inc.
SBFMNasdaqCIK 1402328HealthcareFiscal year ends Dec 31
Reports and events: 192 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-1416:05 ET | 8-K | 5.07 Shareholder vote results | 0001683168-26-007845 |
| 2026-10-0917:25 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-26-007758 |
| 2026-10-0216:49 ET | S-1 | Registration statement | 0001683168-26-007581 |
| 2026-09-1616:05 ET | 8-K | 5.07 Shareholder vote results | 0001683168-26-007193 |
| 2026-09-1117:00 ET | 8-K | 8.01 Other events | 0001683168-26-007090 |
| 2026-08-2816:15 ET | S-1 | Registration statement | 0001683168-26-006779 |
| 2026-08-2816:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001683168-26-006777 |
| 2026-08-1316:05 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001683168-26-006340 |
| 2026-08-0308:52 ET | 8-K | 8.01 Other events | 0001683168-26-005899 |
| 2026-07-2016:27 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001683168-26-005656 |
| 2026-07-1016:54 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001683168-26-005458 |
| 2026-05-2916:05 ET | 8-K | 5.07 Shareholder vote results | 0001683168-26-004387 |
| 2026-05-1916:05 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-26-004116 |
| 2026-05-1316:18 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001683168-26-003819 |
| 2026-05-1216:16 ET | S-1 | Registration statement | 0001683168-26-003726 |
| 2026-04-0916:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-26-002781 |
| 2026-04-0311:58 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001683168-26-002644 |
| 2026-03-0916:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-26-001609 |
| 2026-02-2016:08 ET | 8-K | 5.07 Shareholder vote results | 0001683168-26-001216 |
| 2026-02-0516:16 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001683168-26-000789 |
| 2025-12-1216:05 ET | 8-K | 5.07 Shareholder vote results | 0001683168-25-009103 |
| 2025-11-1316:07 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001683168-25-008328 |
| 2025-10-2316:56 ET | DEF 14A | Proxy statementPeriod 2025-12-11 | 0001683168-25-007747 |
| 2025-09-3016:05 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001683168-25-007338 |
| 2025-08-1216:56 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001683168-25-005981 |
| 2025-08-0517:35 ET | S-1 | Registration statement | 0001683168-25-005644 |
| 2025-05-1917:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-25-003838 |
| 2025-05-1516:06 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001683168-25-003701 |
| 2025-04-0312:02 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-25-002245 |
| 2025-04-0210:50 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-25-002193 |
| 2025-04-0117:05 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001683168-25-002184 |
| 2025-01-1508:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001683168-25-000357 |
| 2024-12-1016:26 ET | 8-K | 5.07 Shareholder vote results | 0001683168-24-008607 |
| 2024-11-0716:40 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-24-007758 |
| 2024-11-0516:05 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001683168-24-007622 |
| 2024-10-2316:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001683168-24-007323 |
| 2024-10-1716:05 ET | DEF 14A | Proxy statementPeriod 2024-12-10 | 0001683168-24-007196 |
| 2024-09-1016:05 ET | 8-K | 8.01 Other events | 0001683168-24-006281 |
| 2024-08-2016:05 ET | 10-Q/A | Quarterly report, amendedPeriod 2024-06-30 | 0001683168-24-005931 |
| 2024-08-1916:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-24-005903 |
| 2024-08-1617:00 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001683168-24-005846 |
| 2024-08-1216:05 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001683168-24-005496 |
| 2024-07-0216:05 ET | 8-K | 5.07 Shareholder vote results | 0001683168-24-004601 |
| 2024-07-0116:05 ET | 8-K | 8.01 Other events | 0001683168-24-004572 |
| 2024-06-1116:00 ET | 8-K | 8.01 Other events | 0001683168-24-004120 |
| 2024-06-0716:00 ET | 8-K | 3.01 Delisting notice | 0001683168-24-004053 |
| 2024-05-2216:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-24-003777 |
| 2024-05-2015:34 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001683168-24-003688 |
| 2024-05-0816:21 ET | 8-K | 4.01 Change of auditor | 0001683168-24-003104 |
| 2024-05-0612:14 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001683168-24-003004 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 12:16 ET. Listed shows no prices and gives no investment advice.